FGEN
FibroGen Inc
Price:  
1.04 
USD
Volume:  
689,544.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FGEN EV/EBITDA

-5069.6%
Upside

As of 2024-07-19, the EV/EBITDA ratio of FibroGen Inc (FGEN) is -0.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FGEN's latest enterprise value is 87.38 mil USD. FGEN's TTM EBITDA according to its financial statements is -216.48 mil USD. Dividing these 2 quantities gives us the above FGEN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 18.4x - 26.8x 23.4x
Forward P/E multiples 22.5x - 26.6x 24.3x
Fair Price (48.80) - (57.77) (51.68)
Upside -4792.4% - -5654.4% -5069.6%
1.04 USD
Stock Price
(51.68) USD
Fair Price

FGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-19 -0.40
2024-07-18 -0.40
2024-07-17 -0.42
2024-07-16 -0.45
2024-07-15 -0.41
2024-07-12 -0.40
2024-07-11 -0.38
2024-07-10 -0.34
2024-07-09 -0.31
2024-07-08 -0.30
2024-07-05 -0.26
2024-07-03 -0.24
2024-07-02 -0.27
2024-07-01 -0.28
2024-06-28 -0.34
2024-06-27 -0.40
2024-06-26 -0.41
2024-06-25 -0.46
2024-06-24 -0.48
2024-06-21 -0.45
2024-06-20 -0.43
2024-06-18 -0.40
2024-06-17 -0.41
2024-06-14 -0.44
2024-06-13 -0.46
2024-06-12 -0.46
2024-06-11 -0.45
2024-06-10 -0.45
2024-06-07 -0.43
2024-06-06 -0.47
2024-06-05 -0.48
2024-06-04 -0.47
2024-06-03 -0.49
2024-05-31 -0.48
2024-05-30 -0.45
2024-05-29 -0.46
2024-05-28 -0.51
2024-05-24 -0.52
2024-05-23 -0.51
2024-05-22 -0.49
2024-05-21 -0.47
2024-05-20 -0.48
2024-05-17 -0.48
2024-05-16 -0.50
2024-05-15 -0.47
2024-05-14 -0.47
2024-05-13 -0.48
2024-05-10 -0.46
2024-05-09 -0.49
2024-05-08 -0.45